Pruss R - Search Results

1

Olesoxime favors oligodendrocyte differentiation through a functional interplay between mitochondria and microtubules.

Magalon K, Le Grand M, El Waly B, Moulis M, Pruss R, Bordet T, Cayre M, Belenguer P, Carré M, Durbec P. Magalon K, et al. Among authors: pruss r. Neuropharmacology. 2016 Dec;111:293-303. doi: 10.1016/j.neuropharm.2016.09.009. Epub 2016 Sep 13. Neuropharmacology. 2016. PMID: 27618742

2

Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model.

Sunyach C, Michaud M, Arnoux T, Bernard-Marissal N, Aebischer J, Latyszenok V, Gouarné C, Raoul C, Pruss RM, Bordet T, Pettmann B. Sunyach C, et al. Among authors: pruss rm. Neuropharmacology. 2012 Jun;62(7):2346-52. doi: 10.1016/j.neuropharm.2012.02.013. Epub 2012 Feb 20. Neuropharmacology. 2012. PMID: 22369784

3

Olesoxime accelerates myelination and promotes repair in models of demyelination.

Magalon K, Zimmer C, Cayre M, Khaldi J, Bourbon C, Robles I, Tardif G, Viola A, Pruss RM, Bordet T, Durbec P. Magalon K, et al. Ann Neurol. 2012 Feb;71(2):213-26. doi: 10.1002/ana.22593. Ann Neurol. 2012. PMID: 22367994

4

Olesoxime prevents microtubule-targeting drug neurotoxicity: selective preservation of EB comets in differentiated neuronal cells.

Rovini A, Carré M, Bordet T, Pruss RM, Braguer D. Rovini A, et al. Biochem Pharmacol. 2010 Sep 15;80(6):884-94. doi: 10.1016/j.bcp.2010.04.018. Epub 2010 Apr 22. Biochem Pharmacol. 2010. PMID: 20417191

5

Protective role of olesoxime against wild-type α-synuclein-induced toxicity in human neuronally differentiated SHSY-5Y cells.

Gouarné C, Tracz J, Paoli MG, Deluca V, Seimandi M, Tardif G, Xilouri M, Stefanis L, Bordet T, Pruss RM. Gouarné C, et al. Among authors: pruss rm. Br J Pharmacol. 2015 Jan;172(1):235-45. doi: 10.1111/bph.12939. Epub 2014 Dec 1. Br J Pharmacol. 2015. PMID: 25220617 Free PMC article.

6

Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain.

Bordet T, Pruss RM. Bordet T, et al. Neurotherapeutics. 2009 Oct;6(4):648-62. doi: 10.1016/j.nurt.2009.07.001. Neurotherapeutics. 2009. PMID: 19789070 Free PMC article. Review.

7

Olesoxime protects embryonic cortical neurons from camptothecin intoxication by a mechanism distinct from BDNF.

Gouarné C, Giraudon-Paoli M, Seimandi M, Biscarrat C, Tardif G, Pruss RM, Bordet T. Gouarné C, et al. Br J Pharmacol. 2013 Apr;168(8):1975-88. doi: 10.1111/bph.12094. Br J Pharmacol. 2013. PMID: 23278424 Free PMC article.

8

Olesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective Compound.

Bordet T, Berna P, Abitbol JL, Pruss RM. Bordet T, et al. Pharmaceuticals (Basel). 2010 Jan 28;3(2):345-368. doi: 10.3390/ph3020345. Pharmaceuticals (Basel). 2010. PMID: 27713255 Free PMC article. Review.

9

TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition.

Schaller S, Paradis S, Ngoh GA, Assaly R, Buisson B, Drouot C, Ostuni MA, Lacapere JJ, Bassissi F, Bordet T, Berdeaux A, Jones SP, Morin D, Pruss RM. Schaller S, et al. Among authors: pruss rm. J Pharmacol Exp Ther. 2010 Jun;333(3):696-706. doi: 10.1124/jpet.110.167486. Epub 2010 Mar 9. J Pharmacol Exp Ther. 2010. PMID: 20215409 Free article.

10

Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.

Clemens LE, Weber JJ, Wlodkowski TT, Yu-Taeger L, Michaud M, Calaminus C, Eckert SH, Gaca J, Weiss A, Magg JC, Jansson EK, Eckert GP, Pichler BJ, Bordet T, Pruss RM, Riess O, Nguyen HP. Clemens LE, et al. Among authors: pruss rm. Brain. 2015 Dec;138(Pt 12):3632-53. doi: 10.1093/brain/awv290. Epub 2015 Oct 21. Brain. 2015. PMID: 26490331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters